Transaction DateRecipientSharesTypePriceValue
12th February 2021Gregory D Wasson682,500Open or private purchase$0.00
29th January 2021Douglas P Baker5,032Open or private sale$47.25$237,762.00
29th January 2021Douglas P Baker4,315Exercise of derivative$7.51$32,405.65
13th January 2021Douglas P Baker5,000Exercise of derivative$7.51$37,550.00
13th January 2021Douglas P Baker5,000Open or private sale$38.89$194,450.00
4th January 2021Douglas P Baker8,334Open or private sale$32.88$274,021.92
4th January 2021Douglas P Baker4,000Exercise of derivative$7.51$30,040.00
4th January 2021Douglas P Baker4,566Exercise of derivative$2.46$11,232.36
31st December 2020Ellen O'Connor Vos802Grant/award etc.$0.00
31st December 2020Gregory D Wasson802Grant/award etc.$0.00
Optimize Rx
Optimize Rx logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985.

Ticker: OPRX
Sector: Technology Services
Industry: Data Processing Services
SEC Central Index Key (CIK): 1448431
Employees: 50
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags